Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Catastrophe Insurance Market Projected to Reach $211.60 billion by 2030 – Exclusive Report by 360iResearch




PUNE, India, March 22, 2024 /PRNewswire/ — The report titledCatastrophe Insurance Market by Type (Catastrophic Health Insurance, Earthquake Insurance, Flood Insurance), Catastrophe Type (Man-made Events, Natural Disasters), Coverage, Providers – Global Forecast 2024-2030 is now available on’s offering, presents an analysis indicating that the market projected to grow from a size of $156.56 billion in 2023 to reach $211.60 billion by 2030, at a CAGR of 4.39% over the forecast period.



Navigating the Future with Enhanced Catastrophe Insurance: A Global Perspective on Risk Mitigation and Recovery

In the ever-evolving global risk landscape, catastrophe insurance stands as a pivotal safeguard, offering comprehensive protection to individuals and organizations against the financial devastations elaborated by unpredictable, large-scale events. These include natural calamities such as earthquakes, floods, hurricanes, and man-made disasters such as terrorist attacks. The significance of catastrophe insurance is deeply rooted in its capability to buffer financial shocks for both insurers and the insured, facilitating swift restoration and stability in the consequences of a disaster. The demand for these insurance solutions is intensifying, driven by the increasing frequency and severity of natural disasters attributed to climate change, rapid urbanization, and the escalating value of assets in areas vulnerable to such catastrophes. Although challenges such as the complexity of accurately pricing policies in an era of climate uncertainty exist, advancements in technology for risk assessment and the development of inclusive, multi-peril coverage options are paving the way forward. Different geographic regions exhibit varying demands and responses to catastrophe insurance. In the Americas, recurring hurricanes and wildfires have led to a surge in insurance uptake, while in the European Union, recent natural disasters have spurred a heightened demand for more robust coverage. Further, the Asia-Pacific region, particularly Japan and China, is experiencing significant market growth due to heightened awareness and regulatory encouragement toward disaster-risk insurance. This global overview underscores the critical role of catastrophe insurance in fostering resilience and continuity in the face of adversity, forecasting a proactive approach toward mitigating risks and securing futures in uncertain times.

Download Sample Report @

Climate Change Escalates Catastrophe Risk, Underscoring the Urgent Need for Adaptation and Insurance Solutions

The increasing severity and frequency of catastrophic events are closely linked to the pace of climate change triggered by the ongoing accumulation of greenhouse gases in the Earth’s atmosphere. This alarming shift in the environment exacerbates natural disasters’ likelihood and intensity by driving global temperatures upwards and causing sea levels to rise, critically disrupting ecosystems. As the planet warms, extreme weather phenomena, including intensifying heatwaves, extended dry spells, and, consequently, heightened wildfire dangers, become more common. Simultaneously, the higher moisture content in warmer air precipitates heavier rainfall, heightening flood risks. Moreover, the melting of polar ice caps and the thermal expansion of the oceans contribute to the increase in sea level, elevating coastal flooding risks and intensifying the destructive power of hurricanes and typhoons. Such climatic aberrations threaten biodiversity and ecosystems, leading to habitat loss and heightening certain regions’ susceptibility to natural disasters. Coupled with changes in land use and rampant deforestation, these climatic changes alter global risk profiles significantly, thereby accelerating the need for comprehensive catastrophe insurance solutions. This reality brings to the forefront the critical importance of adaptive measures and insurance as imperative mechanisms for mitigating the impacts of climate-induced catastrophes.

Navigating the Unpredictable: The Vital Role of Specialized Catastrophe Insurance in Modern Risk Management

In an unpredictable world, catastrophic health insurance emerges as a pivotal safeguard, targeting primarily younger individuals and those with adequate financial reserves for handling routine healthcare costs. This insurance option offers lower monthly premiums and high deductibles, focusing on protecting against substantial medical expenses resulting from emergencies. Beyond healthcare, the landscape of specialized insurance extends to cover many natural and human-made disasters. Earthquake insurance provides indispensable coverage for seismic events, filling the gap left by standard homeowners’ policies, while flood insurance, critical for those in flood-prone zones, steps in where regular insurance steps back, offering protection for both structures and contents against water damage. The emergence of pandemic insurance, accelerated by recent global health crises, underscores the need for businesses to shield themselves against losses from widespread disease outbreaks, ensuring operational continuity and safeguarding employee welfare. Similarly, storm insurance offers redemption in the face of damage from severe weather conditions, including wind and hail. In contrast, terrorism insurance responds to the financial implications of terrorist activities for businesses in high-risk areas. Volcano insurance, though less common, provides coverage for those in the vicinity of potential eruptions, protecting against unique geological threats. Together, these specialized insurance products form a comprehensive risk management framework crucial for navigating the diverse and unforeseen challenges of the modern world with confidence and resilience.

Request Analyst Support @

American International Group, Inc. at the Forefront of Catastrophe Insurance Market with a Strong 11.92% Market Share

The key players in the Catastrophe Insurance Market include The Cigna Group, Chubb Group of Companies, Swiss Re Ltd., American International Group, Inc., Marsh & McLennan Companies, Inc., and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.

Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Catastrophe Insurance Market

We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Catastrophe Insurance Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it’s a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Catastrophe Insurance Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.

Ask Question to ThinkMi @

Dive into the Catastrophe Insurance Market Landscape: Explore 189 Pages of Insights, 384 Tables, and 24 Figures

  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Catastrophe Insurance Market, by Type
  7. Catastrophe Insurance Market, by Catastrophe Type
  8. Catastrophe Insurance Market, by Coverage
  9. Catastrophe Insurance Market, by Providers
  10. Americas Catastrophe Insurance Market
  11. Asia-Pacific Catastrophe Insurance Market
  12. Europe, Middle East & Africa Catastrophe Insurance Market
  13. Competitive Landscape
  14. Competitive Portfolio

Inquire Before Buying @

Related Reports:

  1. Life Insurance Market – Global Forecast 2024-2030
  2. Logistics Insurance Market – Global Forecast 2024-2030
  3. Health Insurance Market – Global Forecast 2024-2030

About 360iResearch

Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.


Contact 360iResearch
Mr. Ketan Rohom
360iResearch Private Limited,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India – 411014.
Email: [email protected]
USA: +1-530-264-8485
India: +91-922-607-7550

To learn more, visit or follow us on LinkedIn, Twitter, and Facebook.

Cision View original content:—exclusive-report-by-360iresearch-302096923.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading